Acceder

Publicaciones - FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA

Cargando...
Ortiz-Fernandez P, Iniesta-Navalon C, Urbieta-Sanz E, Gascon-Canovas JJ. Assessing early therapeutic drug monitoring of adalimumab as a predictor of treatment efficacy and immunogenicity in rheumatic diseases: "early therapeutic drug monitoring of adalimumab". Clin Rheumatol. 2025 Jan 18. doi: 10.1007/s10067-025-07307-0. Online ahead of print. PubMed PMID: 39826047.
AÑO: 2025; IF: 2.9
39826047
Iniesta-Navalon C, Saorin MR, Neira-Torrecillas JM, Rentero-Redondo L, Garcia-Masegosa I, Gil-Almela J, Urbieta-Sanz E. External Evaluation of Population Pharmacokinetic Models of Ustekinumab in Patients with Inflammatory Bowel Disease. Ther Drug Monit. 2025 Apr 3. doi: 10.1097/FTD.0000000000001329. Online ahead of print. PubMed PMID: 40178486.
AÑO: 2025; IF: 2.8
40178486
Serrano Díaz L., Iniesta Navalón C., Gómez Espín R., Nicolás De Prado I., Bernal Morell E., Rentero Redondo L. Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study. Gastroenterologia y Hepatologia. 1 June 2024. 47:553-561. 10.1016/j.gastrohep.2023.08.004
AÑO: 2024; IF: 2.2
37597745
Añez-Castaño R., Iniesta-Navalón C., Almanchel-Rivadeneyra M., García-Villalba E., Oliver-Galera E., Rentero-Redondo L. Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease. European Journal of Hospital Pharmacy. 2024. 10.1136/ejhpharm-2023-004075
AÑO: 2024; IF: 1.6
Serrano Diaz L, Iniesta Navalon C, Gomez Espin R, Nicolas De Prado I, Bernal Morell E, Rentero Redondo L. Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study. Gastroenterol Hepatol. 2024 Jun-Jul;47(6):553-561. doi: 10.1016/j.gastrohep.2023.08.004. Epub 2023 Aug 18. English, Spanish. PubMed PMID: 37597745.
AÑO: 2024; IF: 2.2
37597745
Siguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA